Hitoshi Chiba

4.4k total citations
232 papers, 3.4k citations indexed

About

Hitoshi Chiba is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Hitoshi Chiba has authored 232 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 44 papers in Endocrinology, Diabetes and Metabolism and 41 papers in Surgery. Recurrent topics in Hitoshi Chiba's work include Metabolomics and Mass Spectrometry Studies (36 papers), Liver Disease Diagnosis and Treatment (25 papers) and Peroxisome Proliferator-Activated Receptors (25 papers). Hitoshi Chiba is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (36 papers), Liver Disease Diagnosis and Treatment (25 papers) and Peroxisome Proliferator-Activated Receptors (25 papers). Hitoshi Chiba collaborates with scholars based in Japan, United States and Egypt. Hitoshi Chiba's co-authors include Shu‐Ping Hui, Hirotoshi Fuda, Zhen Chen, Toshihiro Sakurai, Siddabasave Gowda B. Gowda, Yue Wu, Takao Kurosawa, Shu‐Ping Hui, Seiji Takeda and Divyavani Gowda and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Hitoshi Chiba

222 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Chiba Japan 31 1.5k 514 486 483 451 232 3.4k
Zdeněk Dvořák Czechia 42 2.0k 1.4× 210 0.4× 394 0.8× 482 1.0× 248 0.5× 256 6.3k
Orval Mamer Canada 38 2.5k 1.7× 468 0.9× 767 1.6× 379 0.8× 295 0.7× 175 5.2k
Tomoyuki Fujita Japan 36 2.0k 1.4× 541 1.1× 342 0.7× 401 0.8× 311 0.7× 152 4.7k
Vera Jankowski Germany 33 1.3k 0.9× 425 0.8× 455 0.9× 500 1.0× 226 0.5× 133 3.6k
Urs A. Boelsterli Switzerland 45 1.7k 1.2× 312 0.6× 323 0.7× 177 0.4× 639 1.4× 110 5.3k
Neil R. Kitteringham United Kingdom 47 3.1k 2.1× 448 0.9× 504 1.0× 184 0.4× 714 1.6× 92 7.3k
Masakazu Shinohara Japan 38 2.2k 1.5× 691 1.3× 660 1.4× 348 0.7× 457 1.0× 172 4.8k
Aldo Tomasi Italy 40 1.8k 1.2× 306 0.6× 711 1.5× 162 0.3× 544 1.2× 208 6.0k
Han Roelofsen Netherlands 28 1.5k 1.0× 455 0.9× 847 1.7× 171 0.4× 527 1.2× 53 3.3k
Clementina Mesaros United States 30 1.6k 1.1× 190 0.4× 516 1.1× 401 0.8× 195 0.4× 129 3.4k

Countries citing papers authored by Hitoshi Chiba

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Chiba more than expected).

Fields of papers citing papers by Hitoshi Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Chiba. The network helps show where Hitoshi Chiba may publish in the future.

Co-authorship network of co-authors of Hitoshi Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Chiba. A scholar is included among the top collaborators of Hitoshi Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Chiba. Hitoshi Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gowda, Siddabasave Gowda B., Divyavani Gowda, Atsuko Ikeda, et al.. (2025). Plasma Lipidomics of Preadolescent Children: A Hokkaido Study. PubMed. 2025(1). 3106145–3106145. 2 indexed citations
2.
Ho, Hsin‐Jung, et al.. (2025). Vitamin K2 Attenuates Mitochondrial Damage in Renal Proximal Tubular Cells. Journal of Agricultural and Food Chemistry. 73(35). 21857–21868.
3.
Li, Yonghan, Siddabasave Gowda B. Gowda, Divyavani Gowda, et al.. (2024). Alterations in plasma short-chain fatty acids in preadolescence children: The Hokkaido study. Journal of Chromatography B. 1242. 124191–124191.
4.
Gowda, Siddabasave Gowda B., et al.. (2024). Dissecting new lipids and their composition in herbal tea using untargeted LC/MS. Food Chemistry. 447. 138941–138941. 5 indexed citations
5.
Gowda, Siddabasave Gowda B., Pradeep K. Shukla, Divyavani Gowda, et al.. (2024). Sex-Specific Effect of Ethanol on Colon Content Lipidome in a Mice Model Using Nontargeted LC/MS. ACS Omega. 9(14). 16044–16054. 5 indexed citations
6.
Dibwe, Dya Fita, et al.. (2024). Inhibition of Lipid Accumulation and Oxidation in Hepatocytes by Bioactive Bean Extracts. Antioxidants. 13(5). 513–513. 4 indexed citations
7.
Gowda, Siddabasave Gowda B., et al.. (2024). Regio-specific lipid fingerprinting of edible sea cucumbers using LC/MS. Food Research International. 184. 114253–114253. 5 indexed citations
8.
Sakurai, Akiko, Toshihiro Sakurai, Hsin‐Jung Ho, Hitoshi Chiba, & Shu‐Ping Hui. (2024). Kaempferol Improves Cardiolipin and ATP in Hepatic Cells: A Cellular Model Perspective in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. 16(4). 508–508. 3 indexed citations
9.
Ho, Hsin‐Jung, et al.. (2023). Flazin improves mitochondrial dynamics in renal tubular epithelial cells under oxidative stress. Food Bioscience. 56. 103378–103378. 1 indexed citations
10.
Wu, Yue, et al.. (2023). Plasmalogen Profiling in Porcine Brain Tissues by LC-MS/MS. Foods. 12(16). 2990–2990. 1 indexed citations
11.
Tamai, Yasuyuki, Zhen Chen, Yue Wu, et al.. (2021). Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver. Biomedicine & Pharmacotherapy. 135. 111181–111181. 17 indexed citations
12.
Gowda, Siddabasave Gowda B., et al.. (2021). Detection and Structural Characterization of SFAHFA Homologous Series in Mouse Colon Contents by LTQ-Orbitrap-MS and Their Implication in Influenza Virus Infection. Journal of the American Society for Mass Spectrometry. 32(8). 2196–2205. 13 indexed citations
13.
Okazaki, Fumiyoshi, Liqing Zang, Hiroko Nakayama, et al.. (2019). Microbiome Alteration in Type 2 Diabetes Mellitus Model of Zebrafish. Scientific Reports. 9(1). 867–867. 36 indexed citations
14.
Fuda, Hirotoshi, Satoshi Miyanaga, Takayuki Furukawa, et al.. (2019). Flazin as a Promising Nrf2 Pathway Activator. Journal of Agricultural and Food Chemistry. 67(46). 12844–12853. 19 indexed citations
15.
16.
Ma, Yi‐Shing, S. Yoshida, Yu Kobayashi, et al.. (2016). Improvement of Mitochondrial Function and Lipid Utilization by 3,5-dihydroxy-4-methoxybenzyl Alcohol, an Oyster-derived polyphenol, in Oleate-loaded C2C12 Myotubes. Journal of food and nutrition research. 4(8). 498–507. 1 indexed citations
17.
Hui, Shu‐Ping, Hitoshi Chiba, & Takao Kurosawa. (2011). Liquid chromatography–mass spectrometric determination of plasmalogens in human plasma. Analytical and Bioanalytical Chemistry. 400(7). 1923–1931. 27 indexed citations
18.
Kishimoto, Noriaki, Koichi Okita, Shingo Takada, et al.. (2009). Lipoprotein Metabolism, Insulin Resistance, and Adipocytokine Levels in Japanese Female Adolescents With a Normal Body Mass Index and High Body Fat Mass(Vascular Medicine). Japanese Circulation Journal-english Edition. 73(3). 534–539.
19.
Fujisawa, Shinichi, et al.. (1993). [Rapid alteration in serum lipoprotein profile after bile drainage in a patient with acute bile duct obstruction: contribution of cholestasis to cholesteryl ester-dominant ApoE-rich HDL accumulation].. PubMed. 41(6). 679–84. 1 indexed citations
20.
K, Abe, et al.. (1975). [Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide].. PubMed. 17(2). 63–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zdeněk Dvořák Breakdown of academic impact, for papers by Orval Mamer Breakdown of academic impact, for papers by Tomoyuki Fujita Breakdown of academic impact, for papers by Vera Jankowski Breakdown of academic impact, for papers by Urs A. Boelsterli Breakdown of academic impact, for papers by Neil R. Kitteringham Breakdown of academic impact, for papers by Masakazu Shinohara Breakdown of academic impact, for papers by Aldo Tomasi Breakdown of academic impact, for papers by Han Roelofsen Breakdown of academic impact, for papers by Clementina Mesaros
Rankless by CCL
2026